Lv1
30 积分 2024-07-01 加入
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis
3天前
待确认
Evaluation of a Catenary PBPK Model for Predicting the In Vivo Disposition of mAbs Engineered for High-Affinity Binding to FcRn
8天前
已完结
Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies
8天前
已完结
Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effects of FcRn Inhibitors in Mice, Rats, and Monkeys
8天前
已完结
Novel Therapeutic Approach for Psoriasis: Upregulating FcRn to Inhibit Ferroptosis and Alleviate Lesional skin
8天前
已完结
Pharmacokinetics and Safety of Spesolimab in Healthy Chinese Subjects: An Open-Label, Phase I Study
15天前
已完结
A novel agonist antibody to membrane-bound guanylate cyclase receptor, natriuretic peptide receptor 1, induces sustained vasodilation
22天前
已关闭
A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
1个月前
已完结
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
1个月前
已完结
Ongoing and Future Clinical Trials of Pharmacotherapy for Heart Failure
2个月前
已完结
皖公网安备34019202002308
